FDA recall, , Moderate risk
Tandem Diabetes Care Mobi Insulin Pump
The Tandem Mobi insulin pump's Android phone app has a fault that drops the right-away part of an extended dose to zero units.
What happened
Tandem Diabetes Care, Inc. is recalling the Tandem Mobi Insulin Pump with Interoperable Technology, used with the Android Tandem Mobi Mobile app, affecting 4086 users. The recall is for a software defect in the Tandem Mobi mobile application for Android, versions 3.5.4, 3.5.2.2, and 3.5.2.1.
In these versions, the immediate portion of an extended bolus is incorrectly reduced to 0 units when the entered glucose value equals the user's active target glucose value. The later portion is still delivered, but the total insulin delivered may be less than intended.
The application does not provide a distinct alert that the immediate portion was omitted, potentially resulting in unrecognized under-delivery of insulin and hyperglycemia.
The company started the recall on its own, and users were told by e-mail. The company began the recall on October 13, 2026, and the FDA classified it on November 12, 2026. The product was distributed nationwide in the United States and in the Czech Republic.
What to do
If a code on your device is listed below:
- Check the lot against the recall notice and ask your provider or supplier before you stop using it.
Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the UDI-DI, catalog code and model number listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Tandem Mobi Insulin Pump with Interoperable Technology (with Android Tandem Mobi Mobile app)
- UDI-DI
- 00389152547244
- Catalog code
- 1015472
- Software version
- 3.5.4, 3.5.2.2, 3.5.2.1
- Recall number
- Z-0437-2027
- Model number
- 1015472
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 9, 2026
- Sold in
Distributed nationwide and in Czech Republic.
- Recalled by
- Tandem Diabetes Care, Inc.San Diego, California
- Hazard
- Software defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100091
- Recall number
- Z-0437-2027
- Quantity recalled
- 4086 users
- Recall type
- Started by the company
- How the company first told customers
All recalls from Tandem Diabetes Care, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Tandem Diabetes Care began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary
Summary updated

